68 related articles for article (PubMed ID: 7549943)
21. Adaptor molecule Crk is required for sustained phosphorylation of Grb2-associated binder 1 and hepatocyte growth factor-induced cell motility of human synovial sarcoma cell lines.
Watanabe T; Tsuda M; Makino Y; Ichihara S; Sawa H; Minami A; Mochizuki N; Nagashima K; Tanaka S
Mol Cancer Res; 2006 Jul; 4(7):499-510. PubMed ID: 16849525
[TBL] [Abstract][Full Text] [Related]
22. Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma.
Rahimi N; Tremblay E; McAdam L; Park M; Schwall R; Elliott B
Cell Growth Differ; 1996 Feb; 7(2):263-70. PubMed ID: 8822210
[TBL] [Abstract][Full Text] [Related]
23. Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer.
Maulik G; Kijima T; Ma PC; Ghosh SK; Lin J; Shapiro GI; Schaefer E; Tibaldi E; Johnson BE; Salgia R
Clin Cancer Res; 2002 Feb; 8(2):620-7. PubMed ID: 11839685
[TBL] [Abstract][Full Text] [Related]
24. Hepatocyte growth factor region specifically stimulates gastro-intestinal epithelial growth in primary culture.
Fukamachi H; Ichinose M; Tsukada S; Kakei N; Suzuki T; Miki K; Kurokawa K; Masui T
Biochem Biophys Res Commun; 1994 Dec; 205(2):1445-51. PubMed ID: 7802681
[TBL] [Abstract][Full Text] [Related]
25. Induction of epithelial tubules by growth factor HGF depends on the STAT pathway.
Boccaccio C; Andò M; Tamagnone L; Bardelli A; Michieli P; Battistini C; Comoglio PM
Nature; 1998 Jan; 391(6664):285-8. PubMed ID: 9440692
[TBL] [Abstract][Full Text] [Related]
26. Increase in hepatocyte growth factor receptor tyrosine kinase activity in renal carcinoma cells is associated with increased motility partly through phosphoinositide 3-kinase activation.
Nakamura T; Kanda S; Yamamoto K; Kohno T; Maeda K; Matsuyama T; Kanetake H
Oncogene; 2001 Nov; 20(52):7610-23. PubMed ID: 11753639
[TBL] [Abstract][Full Text] [Related]
27. Immediate early gene expression in dog thyrocytes in response to growth, proliferation, and differentiation stimuli.
Deleu S; Pirson I; Clermont F; Nakamura T; Dumont JE; Maenhaut C
J Cell Physiol; 1999 Nov; 181(2):342-54. PubMed ID: 10497313
[TBL] [Abstract][Full Text] [Related]
28. A selective c-met inhibitor blocks an autocrine hepatocyte growth factor growth loop in ANBL-6 cells and prevents migration and adhesion of myeloma cells.
Hov H; Holt RU; Rø TB; Fagerli UM; Hjorth-Hansen H; Baykov V; Christensen JG; Waage A; Sundan A; Børset M
Clin Cancer Res; 2004 Oct; 10(19):6686-94. PubMed ID: 15475459
[TBL] [Abstract][Full Text] [Related]
29. Hepatocyte growth factor is a paracrine regulator of rat prostate epithelial growth.
Kasai S; Sugimura K; Matsumoto K; Nishi N; Kishimoto T; Nakamura T
Biochem Biophys Res Commun; 1996 Nov; 228(2):646-52. PubMed ID: 8920963
[TBL] [Abstract][Full Text] [Related]
30. Selective tumorigenesis in non-parenchymal liver epithelial cell lines by hepatocyte growth factor transfection.
Johnson M; Koukoulis G; Kochhar K; Kubo C; Nakamura T; Iyer A
Cancer Lett; 1995 Sep; 96(1):37-48. PubMed ID: 7553606
[TBL] [Abstract][Full Text] [Related]
31. Hepatocyte growth factor (HGF) receptor expression is inducible and is part of the delayed-early response to HGF.
Boccaccio C; Gaudino G; Gambarotta G; Galimi F; Comoglio PM
J Biol Chem; 1994 Apr; 269(17):12846-51. PubMed ID: 8175699
[TBL] [Abstract][Full Text] [Related]
32. Hepatocyte growth factor induces activation of Nck and phospholipase C-gamma in lung carcinoma cells.
Kochhar KS; Iyer AP
Cancer Lett; 1996 Jul; 104(2):163-9. PubMed ID: 8665484
[TBL] [Abstract][Full Text] [Related]
33. c-met expression in pancreatic cancer and effects of hepatocyte growth factor on pancreatic cancer cell growth.
Kiehne K; Herzig KH; Fölsch UR
Pancreas; 1997 Jul; 15(1):35-40. PubMed ID: 9211490
[TBL] [Abstract][Full Text] [Related]
34. A differentiation switch for genetically modified hepatocytes.
Boccaccio C; Ando' M; Comoglio PM
FASEB J; 2002 Jan; 16(1):120-2. PubMed ID: 11709498
[TBL] [Abstract][Full Text] [Related]
35. Hepatocyte growth factor-induced expression of ornithine decarboxylase, c-met, and c-myc is differently affected by protein kinase inhibitors in human hepatoma cells HepG2.
Desiderio MA; Pogliaghi G; Dansi P
Exp Cell Res; 1998 Aug; 242(2):401-9. PubMed ID: 9683527
[TBL] [Abstract][Full Text] [Related]
36. H441 pulmonary epithelial cell mitogenic effects and signaling pathways in response to HGF and TGF-alpha.
Chess PR; Ryan RM; Finkelstein JN
Exp Lung Res; 1998; 24(1):27-39. PubMed ID: 9457467
[TBL] [Abstract][Full Text] [Related]
37. Regulation of HGF and HGFR gene expression.
Zarnegar R
EXS; 1995; 74():33-49. PubMed ID: 8527900
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model.
Santoni-Rugiu E; Preisegger KH; Kiss A; Audolfsson T; Shiota G; Schmidt EV; Thorgeirsson SS
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9577-82. PubMed ID: 8790372
[TBL] [Abstract][Full Text] [Related]
39. WKYMVm-induced cross-talk between FPR2 and HGF receptor in human prostate epithelial cell line PNT1A.
Cattaneo F; Parisi M; Ammendola R
FEBS Lett; 2013 May; 587(10):1536-42. PubMed ID: 23583448
[TBL] [Abstract][Full Text] [Related]
40. Hepatocyte growth factor stimulates the differentiation of human tracheal epithelia in vitro.
Shen BQ; Panos RJ; Hansen-Guzmán K; Widdicombe JH; Mrsny RJ
Am J Physiol; 1997 Jun; 272(6 Pt 1):L1115-20. PubMed ID: 9227512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
